United States – Pain Management Therapeutics Patients & Market Analysis
United States – Pain Management Therapeutics Market, population and Pipeline Products Analysis
Pain management is one of the fast growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The United States pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The pain management market is fuelled by the segments like arthritis pain, cancer pain, back pain, fibromyalgia, migraine pain, neuropathic pain and post–operative pain relief markets. The largest segment of the United States pain management market is the arthritis while cancer is the most rapidly growing segment. The pediatric pain management market is the smallest segment for the pain management.
Renub Research study titled “United States – Pain Management Therapeutics Patients & Market Analysis” provides a comprehensive assessment of the fast–evolving, high–growth of United States Pain Management Therapeutics Sector. This 73 page report with 46 Figures and 1 Table studies: 10 Pain Management Segment – Market and Patients Population.
The 10 Pain Management Segments covered in the report are as follows
1. Arthritis Pain
2. Migraine Pain
3. Post Operative Pain
4. Cancer Pain
5. Neuropathic Pain
6. Back Pain
7. Fibromyalgia Pain
8. Facial Pain
9. Pediatric Pain
10. Obstetrical Pain
All the above 10 Pain Management Segments covered in this report on the basis of:
I. United States Pain Management Therapeutics Market from the year 2005 – 2018
II. United States Pain Management Patients Population from the year 2005 – 2018
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
Pain management is one of the fast growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The United States pain management therapeutics market has huge potential for growth due to the large population that is affected by medically significant pain. The pain management market is fuelled by the segments like arthritis pain, cancer pain, back pain, fibromyalgia, migraine pain, neuropathic pain and post–operative pain relief markets. The largest segment of the United States pain management market is the arthritis while cancer is the most rapidly growing segment. The pediatric pain management market is the smallest segment for the pain management.
Renub Research study titled “United States – Pain Management Therapeutics Patients & Market Analysis” provides a comprehensive assessment of the fast–evolving, high–growth of United States Pain Management Therapeutics Sector. This 73 page report with 46 Figures and 1 Table studies: 10 Pain Management Segment – Market and Patients Population.
The 10 Pain Management Segments covered in the report are as follows
1. Arthritis Pain
2. Migraine Pain
3. Post Operative Pain
4. Cancer Pain
5. Neuropathic Pain
6. Back Pain
7. Fibromyalgia Pain
8. Facial Pain
9. Pediatric Pain
10. Obstetrical Pain
All the above 10 Pain Management Segments covered in this report on the basis of:
I. United States Pain Management Therapeutics Market from the year 2005 – 2018
II. United States Pain Management Patients Population from the year 2005 – 2018
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. UNITED STATES – PAIN MANAGEMENT THERAPEUTICS MARKET
3. UNITED STATES – PAIN MANAGEMENT PATIENT POPULATION
4. UNITED STATES – PAIN MANAGEMENT THERAPEUTICS MARKET SHARE
5. UNITED STATES – SEGMENT WISE PAIN MANAGEMENT THERAPEUTICS MARKET & POPULATION
5.1 United States – Arthritis Pain Management Therapeutics Analysis (2005 – 2018)
5.1.1 United States – Arthritis Pain Management Therapeutics Market & Forecast
5.1.2 United States – Arthritis Pain Management Therapeutics Population & Forecast
5.2 United States – Migraine Pain Management Therapeutics Market, Population & Forecast (2004 – 2018)
5.2.1 United States – Migraine Pain Management Therapeutics Market & Forecast
5.2.2 United States – Migraine Pain Management Patient Population & Forecast
5.3 United States – Post Operative Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.3.1 United States – Post Operative Pain Management Therapeutics Market & Forecast
5.3.2 United States – Post Operative Pain Management Patient Population & Forecast
5.4 United States – Cancer Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.4.1 United States – Cancer Pain Management Therapeutics Market & Forecast
5.4.2 United States – Cancer Pain Management Patient Population & Forecast
5.5 United States – Neuropathic Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.5.1 United States – Neuropathic Pain Management Therapeutics Market & Forecast
5.5.2 United States – Neuropathic Pain Management Patient Population & Forecast
5.6 United States – Back Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.6.1 United States – Back Pain Management Therapeutics Market & Forecast
5.6.2 United States – Back Pain Management Patient Population & Forecast
5.7 United States – Fibromyalgia Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.7.1 United States – Fibromyalgia Pain Management Therapeutics Market & Forecast
5.7.2 United States – Fibromyalgia Pain Management Patient Population & Forecast
5.8 United States – Facial Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.8.1 United States – Facial Pain Management Therapeutics Market & Forecast
5.8.2 United States – Facial Pain Management Patient Population & Forecast
5.9 United States – Pediatric Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.9.1 United States – Pediatric Pain Management Therapeutics Market & Forecast
5.9.2 United States – Pediatric Pain Management Patient Population & Forecast
5.10 United States – Obstetrical Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.10.1 United States – Obstetrical Pain Management Therapeutics Market & Forecast
6. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET – DRIVING FACTORS
6.1 Elderly Population
6.2 Unmet Need but Strong Pipeline Products
7. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET – CHALLENGES
7.1 Pain Medications, Particularly Opioids, are Associated with Several Side Effects
7.2 Difficulty in Pain Diagnosis Leads to Low Prescription Rates
7.3 Availability of Generics
2. UNITED STATES – PAIN MANAGEMENT THERAPEUTICS MARKET
3. UNITED STATES – PAIN MANAGEMENT PATIENT POPULATION
4. UNITED STATES – PAIN MANAGEMENT THERAPEUTICS MARKET SHARE
5. UNITED STATES – SEGMENT WISE PAIN MANAGEMENT THERAPEUTICS MARKET & POPULATION
5.1 United States – Arthritis Pain Management Therapeutics Analysis (2005 – 2018)
5.1.1 United States – Arthritis Pain Management Therapeutics Market & Forecast
5.1.2 United States – Arthritis Pain Management Therapeutics Population & Forecast
5.2 United States – Migraine Pain Management Therapeutics Market, Population & Forecast (2004 – 2018)
5.2.1 United States – Migraine Pain Management Therapeutics Market & Forecast
5.2.2 United States – Migraine Pain Management Patient Population & Forecast
5.3 United States – Post Operative Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.3.1 United States – Post Operative Pain Management Therapeutics Market & Forecast
5.3.2 United States – Post Operative Pain Management Patient Population & Forecast
5.4 United States – Cancer Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.4.1 United States – Cancer Pain Management Therapeutics Market & Forecast
5.4.2 United States – Cancer Pain Management Patient Population & Forecast
5.5 United States – Neuropathic Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.5.1 United States – Neuropathic Pain Management Therapeutics Market & Forecast
5.5.2 United States – Neuropathic Pain Management Patient Population & Forecast
5.6 United States – Back Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.6.1 United States – Back Pain Management Therapeutics Market & Forecast
5.6.2 United States – Back Pain Management Patient Population & Forecast
5.7 United States – Fibromyalgia Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.7.1 United States – Fibromyalgia Pain Management Therapeutics Market & Forecast
5.7.2 United States – Fibromyalgia Pain Management Patient Population & Forecast
5.8 United States – Facial Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.8.1 United States – Facial Pain Management Therapeutics Market & Forecast
5.8.2 United States – Facial Pain Management Patient Population & Forecast
5.9 United States – Pediatric Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.9.1 United States – Pediatric Pain Management Therapeutics Market & Forecast
5.9.2 United States – Pediatric Pain Management Patient Population & Forecast
5.10 United States – Obstetrical Pain Management Therapeutics Market, Population & Forecast (2005 – 2018)
5.10.1 United States – Obstetrical Pain Management Therapeutics Market & Forecast
6. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET – DRIVING FACTORS
6.1 Elderly Population
6.2 Unmet Need but Strong Pipeline Products
7. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET – CHALLENGES
7.1 Pain Medications, Particularly Opioids, are Associated with Several Side Effects
7.2 Difficulty in Pain Diagnosis Leads to Low Prescription Rates
7.3 Availability of Generics
LIST OF TABLES:
Table 6–1: Pain Management Therapeutics – Pipeline Products, 2013, 2014
Table 6–1: Pain Management Therapeutics – Pipeline Products, 2013, 2014
LIST OF FIGURES:
Figure 2–1: United States – Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 2–2: United States – Forecast for Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 3–1: United States – Pain Management Patient Population (Million), 2005 – 2013
Figure 3–2: United States – Forecast for Pain Management Patient Population (Million), 2014 – 2018
Figure 4–1: United States – Pain Management Therapeutics Market Share (Percent), 2005 – 2013
Figure 4–2: United States – Forecast for Pain Management Therapeutics Market Share (Percent), 2014 – 2018
Figure 5–1: United States – Arthritis Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–2: United States – Forecast for Arthritis Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–3: United States – Arthritis Pain Management Patient Population (Million), 2005 – 2013
Figure 5–4: United States – Forecast for Arthritis Pain Management Patient Population (Million), 2014 – 2018
Figure 5–5: United States – Migraine Pain Management Therapeutics Market (Million US$), 2004 – 2013
Figure 5–6: United States – Forecast for Migraine Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–7: United States – Migraine Pain Management Patient Population (Million), 2004 – 2013
Figure 5–8: United States – Forecast for Migraine Pain Management Patient Population (Million), 2014 – 2018
Figure 5–9: United States – Post Operative Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–10: United States – Forecast for Post Operative Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–11: United States – Post Operative Pain Management Patient Population (Million), 2005 – 2013
Figure 5–12: United States – Forecast for Post Operative Pain Management Patient Population (Million), 2014 – 2018
Figure 5–13: United States – Cancer Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–14: United States – Forecast for Cancer Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–15: United States – Cancer Pain Management Patient Population (Million), 2005 – 2013
Figure 5–16: United States – Forecast for Cancer Pain Management Patient Population (Million), 2014 – 2018
Figure 5–17: United States – Neuropathic Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–18: United States – Forecast for Neuropathic Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–19: United States – Neuropathic Pain Management Patient Population (Million), 2005 – 2013
Figure 5–20: United States – Forecast for Neuropathic Pain Management Patient Population (Million), 2014 – 2018
Figure 5–21: United States – Back Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–22: United States – Forecast for Back Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–23: United States – Back Pain Management Patient Population (Million), 2005 – 2013
Figure 5–24: United States – Forecast for Back Pain Management Patient Population (Million), 2014 – 2018
Figure 5–25: United States – Fibromyalgia Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–26: United States – Forecast for Fibromyalgia Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–27: United States – Fibromyalgia Pain Management Patient Population (Million), 2005 – 2013
Figure 5–28: United States – Forecast for Fibromyalgia Pain Management Patient Population (Million), 2014 – 2018
Figure 5–29: United States – Facial Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–30: United States – Forecast for Facial Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–31: United States – Facial Pain Management Patient Population (Million), 2005 – 2013
Figure 5–32: United States – Forecast for Facial Pain Management Patient Population (Million), 2014 – 2018
Figure 5–33: United States – Pediatric Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–34: United States – Forecast for Pediatric Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–35: United States – Pediatric Pain Management Patient Population (Number), 2005 – 2013
Figure 5–36: United States – Forecast for Pediatric Pain Management Patient Population (Number), 2014 – 2018
Figure 5–37: United States – Obstetrical Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–38: United States – Forecast for Obstetrical Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 6–1: United States – Elderly Population 60 Years and Above (Million), 2005 – 2013
Figure 6–2: United States – Forecast for Elderly Population 60 Years and Above (Million), 2014 – 2018
Figure 2–1: United States – Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 2–2: United States – Forecast for Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 3–1: United States – Pain Management Patient Population (Million), 2005 – 2013
Figure 3–2: United States – Forecast for Pain Management Patient Population (Million), 2014 – 2018
Figure 4–1: United States – Pain Management Therapeutics Market Share (Percent), 2005 – 2013
Figure 4–2: United States – Forecast for Pain Management Therapeutics Market Share (Percent), 2014 – 2018
Figure 5–1: United States – Arthritis Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–2: United States – Forecast for Arthritis Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–3: United States – Arthritis Pain Management Patient Population (Million), 2005 – 2013
Figure 5–4: United States – Forecast for Arthritis Pain Management Patient Population (Million), 2014 – 2018
Figure 5–5: United States – Migraine Pain Management Therapeutics Market (Million US$), 2004 – 2013
Figure 5–6: United States – Forecast for Migraine Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–7: United States – Migraine Pain Management Patient Population (Million), 2004 – 2013
Figure 5–8: United States – Forecast for Migraine Pain Management Patient Population (Million), 2014 – 2018
Figure 5–9: United States – Post Operative Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–10: United States – Forecast for Post Operative Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–11: United States – Post Operative Pain Management Patient Population (Million), 2005 – 2013
Figure 5–12: United States – Forecast for Post Operative Pain Management Patient Population (Million), 2014 – 2018
Figure 5–13: United States – Cancer Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–14: United States – Forecast for Cancer Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–15: United States – Cancer Pain Management Patient Population (Million), 2005 – 2013
Figure 5–16: United States – Forecast for Cancer Pain Management Patient Population (Million), 2014 – 2018
Figure 5–17: United States – Neuropathic Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–18: United States – Forecast for Neuropathic Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–19: United States – Neuropathic Pain Management Patient Population (Million), 2005 – 2013
Figure 5–20: United States – Forecast for Neuropathic Pain Management Patient Population (Million), 2014 – 2018
Figure 5–21: United States – Back Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–22: United States – Forecast for Back Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–23: United States – Back Pain Management Patient Population (Million), 2005 – 2013
Figure 5–24: United States – Forecast for Back Pain Management Patient Population (Million), 2014 – 2018
Figure 5–25: United States – Fibromyalgia Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–26: United States – Forecast for Fibromyalgia Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–27: United States – Fibromyalgia Pain Management Patient Population (Million), 2005 – 2013
Figure 5–28: United States – Forecast for Fibromyalgia Pain Management Patient Population (Million), 2014 – 2018
Figure 5–29: United States – Facial Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–30: United States – Forecast for Facial Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–31: United States – Facial Pain Management Patient Population (Million), 2005 – 2013
Figure 5–32: United States – Forecast for Facial Pain Management Patient Population (Million), 2014 – 2018
Figure 5–33: United States – Pediatric Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–34: United States – Forecast for Pediatric Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 5–35: United States – Pediatric Pain Management Patient Population (Number), 2005 – 2013
Figure 5–36: United States – Forecast for Pediatric Pain Management Patient Population (Number), 2014 – 2018
Figure 5–37: United States – Obstetrical Pain Management Therapeutics Market (Million US$), 2005 – 2013
Figure 5–38: United States – Forecast for Obstetrical Pain Management Therapeutics Market (Million US$), 2014 – 2018
Figure 6–1: United States – Elderly Population 60 Years and Above (Million), 2005 – 2013
Figure 6–2: United States – Forecast for Elderly Population 60 Years and Above (Million), 2014 – 2018
